FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Ostar Beauty Selling Unapproved Medical Devices: FDA

[ Price : $8.95]

FDA warns Chinas Ostar Beauty Sci-Tech about illegally marketing unapproved medical devices.

Multiple Violations in Lengthy Biomic Inspection

[ Price : $8.95]

FDA warns Charlottesville, VA-based ION Intelligence of Nature about multiple violations in its production of drugs and dietary su...

Spinearts Scarlet Anterior Cervical Cage Cleared

[ Price : $8.95]

FDA clears a Spineart 510(k) for its Scarlet AC-Ti secured anterior cervical cage.

Teva Spurns FDAs Beta-Lactam Drug Recommendation

[ Price : $8.95]

Teva says FDA should drop its recommendation for the use of dedicated manufacturing facilities for ezetimibe to prevent cross-cont...

ICH Pharmacoepidemiological Study Guidance Out

[ Price : $8.95]

FDA publishes for comment the International Council for Harmonization M14 guidance on general principles for planning, designing, ...

Sanofi Sarclisa sBLA Accepted for Priority Review

[ Price : $8.95]

FDA accepts for priority review a Sanofi supplemental BLA for Sarclisa (isatuximab) in combination with standard of care for treat...

Workshop on Patient-Generated Health Data

[ Price : $8.95]

FDA co-sponsors a 6/26-27 public workshop on using patient-generated health data in medical device development.

Platform Technology Designation Guidance

[ Price : $8.95]

FDA publishes a draft guidance on the drug development platform technology designation program.

FDA Seeks to Withdraw 4 NDAs

[ Price : $8.95]

Federal Register notice: CDER proposes to withdraw approval of four NDAs after the application holders repeatedly failed to file r...

Pfizer Wins Priority Review Voucher for Paxlovid

[ Price : $8.95]

Federal Register notice: FDA issues a priority review voucher to Pfizer after determining that its Paxlovid tablets meet the crite...